Revamilast

DB11838InvestigationalSmall molecule

Revamilast has been used in trials studying the treatment of Asthma and Rheumatoid Arthritis.

Chemical structure of Revamilast
Mechanism
Curator reviewed
Formula / weight
C18H9Cl2F2N3O4 · 440.18 g/mol (avg)

Resolves to

Compound
UNII30LE65637TCAS893555-90-3PubChem11546664
Structure
InChIKeyIXQHNBONEVULTL-UHFFFAOYSA-NSMILES[O-][N+]1=CC(Cl)=C(NC(=O)C2=CC=C(OC(F)F)C3=C2C2=CN=CC=C2O3)C(Cl)=C1
Targets
P27815PDE4AQ07343PDE4BQ08499PDE4D

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Revamilast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In